China Universal Asset Management Co., Ltd. - KINNATE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 72 filers reported holding KINNATE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Links
Filings
External links
Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,681
-9.2%
1,201
+96.6%
0.00%
-100.0%
Q2 2023$1,851
-50.5%
611
+2.2%
0.00%0.0%
Q1 2023$3,738
+36.8%
598
+33.5%
0.00%0.0%
Q4 2022$2,733
-45.3%
448
+8.2%
0.00%
-50.0%
Q3 2022$5,000–414–0.00%–
 Download
Other shareholders

There were no reported owners of KINNATE BIOPHARMA INC in Q1 2023.

NameSharesValueWeighting ↓
View complete list of KINNATE BIOPHARMA INC shareholders